Literature DB >> 3285291

bcr genes and transcripts.

B Lifshitz1, E Fainstein, C Marcelle, E Shtivelman, R Amson, R P Gale, E Canaani.   

Abstract

Human chronic myelogenous leukemia (CML) is a clonal hematologic disorder. CML is characterized by the t(9:22) chromosome translocation which results in translocation of the oncogene abl from chromosome 9 into the breakpoint cluster region (bcr) gene on chromosome 22. We cloned and characterized the cDNA of the normal bcr gene. The bcr gene codes for a protein of 1271 amino acids. The open reading frame is preceded by a region high in GC. At the 5' of this region we identified several GC motifs which are probably involved in the initiation of bcr transcription. bcr transcripts of 7.0 and 4.5 kb are expressed in all cell types examined. These transcripts share all cDNA sequences analysed, including the 5' untranslated region. The latter as well as 902 or 927 amino acids are included within the CML-specific bcr-abl mRNA transcribed from the chimeric bcr-abl gene on chromosome 22. In addition to the complete bcr gene, the human genome contains 3 bcr-related genes containing the last seven exons of the intact bcr gene. One of these genes was analysed in detail and showed high sequence homology with the latter. The three bcr-related genes were probably derived from the intact gene by subsequent steps of duplication.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285291

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Human bcr-abl gene has a lethal effect on embryogenesis.

Authors:  N Heisterkamp; G Jenster; D Kioussis; P K Pattengale; J Groffen
Journal:  Transgenic Res       Date:  1991-12       Impact factor: 2.788

2.  Unique organization of the human BCR gene promoter.

Authors:  Q S Zhu; N Heisterkamp; J Groffen
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 3.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

4.  Nuclear and cytoplasmic location of the FER tyrosine kinase.

Authors:  Q L Hao; D K Ferris; G White; N Heisterkamp; J Groffen
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

5.  The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.

Authors:  A J Muller; O N Witte
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes.

Authors:  C Hall; W C Sin; M Teo; G J Michael; P Smith; J M Dong; H H Lim; E Manser; N K Spurr; T A Jones
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.

Authors:  Walid Al Achkar; Abdulsamad Wafa; Bashar Yousef Ali; Marina Manvelyan; Thomas Liehr
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

8.  Molecular studies of DiGeorge syndrome.

Authors:  W J Fibison; M Budarf; H McDermid; F Greenberg; B S Emanuel
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

9.  A Drosophila rotund transcript expressed during spermatogenesis and imaginal disc morphogenesis encodes a protein which is similar to human Rac GTPase-activating (racGAP) proteins.

Authors:  M Agnel; L Röder; C Vola; R Griffin-Shea
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  The human Vpre B gene is located on chromosome 22 near a cluster of V lambda gene segments.

Authors:  S R Bauer; K Huebner; M Budarf; J Finan; J Erikson; B S Emanuel; P C Nowell; C M Croce; F Melchers
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.